Ability of sickle cells to scavenge endothelium-derived nitric oxide is reduced

Acta Pharmacologica Sinica

Volumn 23, Issue 11, 2002, Pages 967-973

  Olmos, Leopoldo ^a   Mombouli, Jean Vivien ^b   Wasserstrum, Nathan ^a   Vanhoutte, Paul M ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Marien Ngouabi University   (Congo)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Endothelium; Erythrocytes; Microcirculation; Nitric oxide; Sickle cell anemia; Vascular smooth muscle

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CAROTID ARTERY; CONTROLLED STUDY; DOG; ENDOTHELIUM; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MICROCIRCULATION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; NONHUMAN; SICKLE CELL; SICKLE CELL ANEMIA; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANEMIA, SICKLE CELL; ANIMALS; DOGS; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; ERYTHROCYTES; FEMALE; HUMANS; NITRIC OXIDE; OXYHEMOGLOBINS; PHENYLEPHRINE; PREGNANCY;

EID: 0036843943     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kaul DK, Nagel RL. Sickle cell vasoocclusion: Many issues and some answers. Experienta 1993; 49: 5-15.
2. Wicke TM, Eckman JR. Molecular basis of sickle cell-endothelial cell interactions. Curr Opin Hematol 1996; 3: 118-24.
3. French JA 2nd, Kenny D, Scott JP, Hoffmann RG, Wood JD, Hudetz AG, Hillery CA. Mechanisms of stroke in sickle cell disease: Sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood 1997; 89: 4591-9.
4. Hillery CA. Potential therapeutic approaches for the treatment of vaso-occlusion in sickle cell disease. Curr Opin Hematol 1998; 5: 151-5.
5. Ballas SK, Larner J, Smith ED, Surrey S, Schwartz E, Rappaport EF. Rheologic predictors of the severity of the painful sickle cell crisis. Blood 1988; 72: 1216-23.
6. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999; 107: 300-2.
7. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 2000; 95: 1293-300.
8. Space SL, Lane PA, Pickett CK, Weil JV. Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am J Hematol 2000; 63: 200-4.
9. Brittain HA, Eckman JR, Wick TM. Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 1992; 120: 538-45.
10. Barabino GA, Liu XD, Ewenstein BM, Kaul DK. Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior. Blood 1999; 93: 1422-9.
11. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999; 26: 74-84.
12. Shiu YT, Udden MM, McIntire LV. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. Blood 2000; 95: 3232-41.
13. Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 1998; 92: 3924-35.
14. Vanhoutte PM, Perrault LP, Vilaine JP. Endothelial dysfunction and vascular disease. From: The Endothelium in Clinical Practice. In: Rubanyi G, Dzau VJ, editors. New York: Marcel Dekker Inc; 1997. p 265-89.
15. Vanhoutte PM. Endothelial dysfunction and vascular disease. In: Endothelium, Nitric Oxide and Atherosclerosis. In: Panza Julio A, Cannon III Richard O, editors. From Basic Mechanisms to Clinical Implications. Armonk, NY: Futura Publishing Co, Inc; 1999. p 79-95.
16. Mosseri M, Bartlett-Pandite AN, Wenc K, Isner JM, Weinstein R. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J 1993; 126: 338-46.
17. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
18. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
19. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708-16.
20. Gillespie JS, Sheng H. Influence of hemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle. Br J Pharmacol 1988; 95: 1151-6.
21. Evans HG, Ryley HC, Hallett I, Lewis MJ. Human red blood cells inhibits endothelium-derived relaxing factor (EDRF) activity. Eur J Pharmacol 1989; 163: 361-4.
22. Mombouli J-V, Vanhoutte PM. Kinins and endotheliumdependent relaxations to converting enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharmacol 1991; 18: 926-7.
23. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor(s). Am J Physiol 1986; 250: H822-H827.
24. Hammerman SI, Klings ES, Hendra KP, Upchurch GR Jr, Rishikof DC, Loscalzo J, Farber HW Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol 1999; 277: H1579-H1592.